TY - JOUR
T1 - Postoperative Liver Failure
T2 - Definitions, Risk factors, Prediction Models and Prevention Strategies
AU - Merath, Katiuscha
AU - Tiwari, Ankur
AU - Court, Colin
AU - Parikh, Alexander
AU - Dillhoff, Mary
AU - Cloyd, Jordan
AU - Ejaz, Aslam
AU - Pawlik, Timothy M.
N1 - Publisher Copyright:
© 2023, The Society for Surgery of the Alimentary Tract.
PY - 2023/11
Y1 - 2023/11
N2 - Background: Liver resection is the treatment for a variety of benign and malignant conditions. Despite advances in preoperative selection, surgical technique, and perioperative management, post hepatectomy liver failure (PHLF) is still a leading cause of morbidity and mortality following liver resection. Methods: A review of the literature was performed utilizing MEDLINE/PubMed and Web of Science databases in May of 2023. The MESH terms “liver failure,” “liver insufficiency,” and “hepatic failure” in combination with “liver surgery,” “liver resection,” and “hepatectomy” were searched in the title and/or abstract. The references of relevant articles were reviewed to identify additional eligible publications. Results: PHLF can have devastating physiological consequences. In general, risk factors can be categorized as patient-related, primary liver function-related, or perioperative factors. Currently, no effective treatment options are available and the management of PHLF is largely supportive. Therefore, identifying risk factors and preventative strategies for PHLF is paramount. Ensuring an adequate future liver remnant is important to mitigate risk of PHLF. Dynamic liver function tests provide more objective assessment of liver function based on the metabolic capacity of the liver and have the advantage of easy administration, low cost, and easy reproducibility. Conclusion: Given the absence of randomized data specifically related to the management of PHLF, current strategies are based on the principles of management of acute liver failure from any cause. In addition, goal-directed therapy for organ dysfunction, as well as identification and treatment of reversible factors in the postoperative period are critical.
AB - Background: Liver resection is the treatment for a variety of benign and malignant conditions. Despite advances in preoperative selection, surgical technique, and perioperative management, post hepatectomy liver failure (PHLF) is still a leading cause of morbidity and mortality following liver resection. Methods: A review of the literature was performed utilizing MEDLINE/PubMed and Web of Science databases in May of 2023. The MESH terms “liver failure,” “liver insufficiency,” and “hepatic failure” in combination with “liver surgery,” “liver resection,” and “hepatectomy” were searched in the title and/or abstract. The references of relevant articles were reviewed to identify additional eligible publications. Results: PHLF can have devastating physiological consequences. In general, risk factors can be categorized as patient-related, primary liver function-related, or perioperative factors. Currently, no effective treatment options are available and the management of PHLF is largely supportive. Therefore, identifying risk factors and preventative strategies for PHLF is paramount. Ensuring an adequate future liver remnant is important to mitigate risk of PHLF. Dynamic liver function tests provide more objective assessment of liver function based on the metabolic capacity of the liver and have the advantage of easy administration, low cost, and easy reproducibility. Conclusion: Given the absence of randomized data specifically related to the management of PHLF, current strategies are based on the principles of management of acute liver failure from any cause. In addition, goal-directed therapy for organ dysfunction, as well as identification and treatment of reversible factors in the postoperative period are critical.
KW - Future liver remnant
KW - Hepatectomy
KW - Liver failure
KW - Liver insufficiency
KW - Liver resection
UR - http://www.scopus.com/inward/record.url?scp=85173078477&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85173078477&partnerID=8YFLogxK
U2 - 10.1007/s11605-023-05834-2
DO - 10.1007/s11605-023-05834-2
M3 - Review article
C2 - 37783906
AN - SCOPUS:85173078477
SN - 1091-255X
VL - 27
SP - 2640
EP - 2649
JO - Journal of Gastrointestinal Surgery
JF - Journal of Gastrointestinal Surgery
IS - 11
ER -